Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance.

MLA

Palmer, Douglas C., et al. “Cish Actively Silences TCR Signaling in CD8+ T Cells to Maintain Tumor Tolerance.” The Journal of Experimental Medicine, vol. 212, no. 12, Nov. 2015, pp. 2095–113. EBSCOhost, https://doi.org/10.1084/jem.20150304.

APA

Palmer, D. C., Guittard, G. C., Franco, Z., Crompton, J. G., Eil, R. L., Patel, S. J., Ji, Y., Van Panhuys, N., Klebanoff, C. A., Sukumar, M., Clever, D., Chichura, A., Roychoudhuri, R., Varma, R., Wang, E., Gattinoni, L., Marincola, F. M., Balagopalan, L., Samelson, L. E., & Restifo, N. P. (2015). Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance. The Journal of Experimental Medicine, 212(12), 2095–2113. https://doi.org/10.1084/jem.20150304

Chicago

Palmer, Douglas C, Geoffrey C Guittard, Zulmarie Franco, Joseph G Crompton, Robert L Eil, Shashank J Patel, Yun Ji, et al. 2015. “Cish Actively Silences TCR Signaling in CD8+ T Cells to Maintain Tumor Tolerance.” The Journal of Experimental Medicine 212 (12): 2095–2113. doi:10.1084/jem.20150304.